FindTrial
Sign In

Multicenter study of PA28gamma as a potential prognostic markers in OSCC

Proteasomal activator PA28gamma: a biological behavior regulator in OSCC cells anda potential predictor for the prognosis of patients with OSCC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRC-15007133
Enrollment
Unknown
Registered
2015-09-20
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral squamous cell carcinoma

Interventions

High express PA28gamma group andlow express PA28gamma group:No intervention

Sponsors

West China Hospital of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: OSCC patients at West China Hospital of Stomatology, Sichuan University (Chengdu, China) from January 2002; OSCC patients at Guangdong Stomatological Hospital between May 2003 andAugust 2009.

Exclusion criteria

Exclusion criteria: Not OSCC patients

Design outcomes

Primary

MeasureTime frame
The expression level of PA28gamma protein;—

Countries

China

Contacts

Public ContactChen Qianming
qmchen@scu.edu.cn+86 028 85405251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026